Has the practice of radiation oncology for locally advanced and metastatic non-small-cell lung cancer changed in Canada?

Current Oncology

Volumn 17, Issue 1, 2010, Pages 33-40

  Han, Kathy ^a   Bezjak, A ^a   Xu, W ^b   Kane, G ^c  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

Non small cell lung cancer; Palliation; Radiation; Survey

Indexed keywords

ADVANCED CANCER; ARTICLE; BRACHYTHERAPY; CANADA; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL PRACTICE; COMPUTER ASSISTED TOMOGRAPHY; EVIDENCE BASED PRACTICE; EXTERNAL BEAM RADIOTHERAPY; HUMAN; LUNG NON SMALL CELL CANCER; MEDICAL SPECIALIST; RADIATION DOSE FRACTIONATION; TREATMENT PLANNING;

EID: 75849160173     PISSN: None     EISSN: 17187729     Source Type: Journal    
DOI: 10.3747/co.v17i1.387     Document Type: Article

References (27)

1. Parkin DM. Global cancer statistics in the year 2000. Lancet Oncol 2001;2:533-43.
2. Duncan G, Duncan W, Maher EJ. Patterns of palliative radiotherapy in Canada. Clin Oncol (R Coll Radiol) 1993;5:92-7.
3. Raby B, Pater J, Mackillop WJ. Does knowledge guide practice? Another look at the management of non-small-cell lung cancer. J Clin Oncol 1995;13:1904-11.
4. Macbeth FR, Bolger JJ, Hopwood P, et al. on behalf of the Medical Research Council Lung Cancer Working Party. Randomized trial of palliative two-fraction versus more intensive 13-fraction radiotherapy for patients with inoperable non-small cell lung cancer and good performance status. Clin Oncol (R Coll Radiol) 1996;8:167-75.
5. Rees GJ, Devrell CE, Barley VL, Newman HF. Palliative radiotherapy for lung cancer: two versus five fractions. Clin Oncol (R Coll Radiol) 1997;9:90-5.
6. Reinfuss M, Glinski B, Kowalska T, et al. Radiotherapy for stage iii, inoperable, asymptomatic small cell lung cancer. Final results of a prospective randomized study (240 patients) [French]. Cancer Radiother 1999;3:475-9.
7. Nestle U, Nieder C, Walter K, et al. A palliative accelerated irradiation regimen for advanced non-small-cell lung cancer vs. conventionally fractionated 60 Gy: results of a randomized equivalence study. Int J Radiat Oncol Biol Phys 2000;48:95-103.
8. Bezjak A, Dixon P, Brundage M, et al. Randomized phase III trial of single versus fractionated thoracic radiation in the palliation of patients with lung cancer (NCIC CTG SC.15). Int J Radiat Oncol Biol Phys 2002;54:719-28.
9. Sundstrøm S, Bremnes R, Aasebø U, et al. Hypofractionated palliative radiotherapy (17 Gy per two fractions) in advanced non-small-cell lung carcinoma is comparable to standard fractionation for symptom control and survival: a national phase III trial. J Clin Oncol 2004;22:801-10.
10. Erridge SC, Gaze MN, Price A, et al. Symptom control and quality of life in people with lung cancer: a randomised trial of two palliative radiotherapy fractionation schedules. Clin Oncol (R Coll Radiol) 2005;17:61-7.
11. Senkus-Konefka E, Dziadziuszko R, Bednaruk-Młyński E, et al. A prospective, randomised study to compare two palliative radiotherapy schedules for non-small-cell lung cancer (NSCLC). Br J Cancer 2005;92:1038-45.
12. Kramer GW, Wanders SL, Noordijk EM, et al. Results of the Dutch National study of the palliative effect of irradiation using two different treatment schemes for non-small-cell lung cancer. J Clin Oncol 2005;23:2962-70.
13. Tai P, Yu E, Battista J, Van Dyk J. Radiation treatment of lung cancer-patterns of practice in Canada. Radiother Oncol 2004;71:167-74.
14. Lester JF, Macbeth FR, Toy E, Coles B. Palliative radiotherapy regimens for non-small cell lung cancer. Cochrane Database Syst Rev 2006;(4):CD002143.
15. Choy H, Shyr Y, Cmelak AJ, Mohr PJ, Johnson DH. Patterns of practice survey for nonsmall cell lung carcinoma in the U.S. Cancer 2000;88:1336-46.
16. Cmelak AJ, Choy H, Shyr Y, Mohr P, Glantz MJ, Johnson DH. National survey on prophylactic cranial irradiation: differences in practice patterns between medical and radiation oncologists. Int J Radiat Oncol Biol Phys 1999;44:157-62.
17. Falk SJ, Girling DJ, White RJ, et al. on behalf of the Medical Research Council Lung Cancer Working Party. Immediate versus delayed palliative thoracic radiotherapy in patients with unresectable locally advanced non-small cell lung cancer and minimal thoracic symptoms: randomised controlled trial. BMJ 2002;325:465.
18. Non-Small Cell Lung Cancer Collaborative Group. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. BMJ 1995;311:899-909.
19. Pritchard RS, Anthony SP. Chemotherapy plus radiotherapy compared with radiotherapy alone in the treatment of locally advanced, unresectable, non-small-cell lung cancer. A meta-analysis. Ann Intern Med 1996;125:723-9.
20. Rowell NP, O'rourke NP. Concurrent chemoradiotherapy in non-small cell lung cancer. Cochrane Database Syst Rev 2004;(4):CD002140.
21. Gridelli C, Ardizzoni A, Le Chevalier T, et al. Treatment of advanced non-small-cell lung cancer patients with ECOG performance status 2: results of an European Experts Panel. Ann Oncol 2004;15:419-26.
22. Pfister DG, Johnson DH, Azzoli CG, et al. on behalf of the American Society of Clinical Oncology. American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003. J Clin Oncol 2004;22:330-53.
23. Langer CJ. Neglected and underrepresented subpopulations: elderly and performance status 2 patients with advanced-stage non-small-cell lung cancer. Clin Lung Cancer 2006;7(suppl 4):S126-37.
24. Ung YC, Yu E, Falkson C, Haynes AE, Stys-Norman D, Evans WK on behalf of the Lung Cancer Disease Site Group of Cancer Care Ontario's Program in Evidence-Based Care. The role of high-dose-rate brachytherapy in the palliation of symptoms in patients with non-small-cell lung cancer: a systematic review. Brachytherapy 2006;5:189-202.
25. Cardona AF, Reveiz L, Ospina EG, Ospina V, Yepes A. Palliative endobronchial brachytherapy for non-small cell lung cancer. Cochrane Database Syst Rev 2008;(2):CD004284.
26. Maziak DE, Markman BR, Mackay JA, Evans WK on behalf of the Lung Cancer Disease Site Group of Cancer Care Ontario's Program in Evidence-Based Care. The Role of Photodynamic Therapy (PDT) in Patients with Non-Small Cell Lung Cancer: A Clinical Practice Guideline. Toronto, ON: Cancer Care Ontario; 2005. [Available online at: www.cancercare.on.ca/common/ pages/UserFile.aspx? fileId=14190; cited November 1, 2008]
27. Graham ID, Brouwers M, Davies C, Tetroe J. Ontario doctors' attitudes toward and use of clinical practice guidelines in oncology. J Eval Clin Pract 2007;13:607-15.